Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06401824
Title Sacituzumab Govitecan and Bevacizumab for NSCLC Brain Metastases
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Maastricht University Medical Center
Indications
Therapies
Age Groups: senior | adult
Covered Countries NLD


No variant requirements are available.